Citius PharmaceuticalsCTXR 
$0.53-1.85%24h
-1.85%24h
Global rank22153
Market cap$80.19M
Change 7d-8.15%
YTD Performance-30.26%
SP500 benchmarkUnderperform
P/E-2.41
P/S0
Revenue$0
Earnings-$32.54M
Dividend yield-
Main Sector
Healthcare
Citius Pharmaceuticals (CTXR) Cash on Hand
CTXR Cash on Hand in 2022: $26.48M
According to Citius Pharmaceuticals latest financial reports the cash on hand of CTXR is $26.48M, an decrease of -36.51% to 2022. At the end of 2022 company had $41.71M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
CTXR Cash on Hand History from 2018 to 2023
-
Value:-
CTXR Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $26.48M | -36.51% |
| 2022 | $41.71M | -40.47% |
| 2021 | $70.07M | 405.59% |
| 2020 | $13.86M | 75.58% |
| 2019 | $7.89M | -14.05% |
| 2018 | $9.18M | - |
View the Top Cash on Hand Companies 
